Hurson, Amber N.
Hamilton, Alina M.
Olsson, Linnea T.
Kirk, Erin L.
Sherman, Mark E.
Calhoun, Benjamin C.
Geradts, Joseph
Troester, Melissa A. http://orcid.org/0000-0001-9506-6624
Funding for this research was provided by:
Susan G. Komen (OGUNC1202)
Division of Cancer Epidemiology and Genetics, National Cancer Institute (P01CA151135, P50-CA058223, P30CA016086)
Article History
Received: 5 August 2022
Accepted: 5 February 2023
First Online: 9 March 2023
Declarations
:
: The University of North Carolina, Chapel Hill has a license of intellectual property interest in GeneCentric Diagnostics and BioClassifier, LLC, which may be used in this study. The University of North Carolina, Chapel Hill may benefit from this interest that is/are related to this research. The terms of this arrangement have been reviewed and approved by the University of North Carolina, Chapel Hill Conflict of Interest Program in accordance with its conflict of interest policies.
: All study procedures were approved by the University of North Carolina School of Medicine Institutional Review Board.
: All participants provided written informed consent.